Medline Industries has signed a definitive agreement for a majority investment from a collaboration made up of funds managed by private-equity firms, Blackstone, Carlyle and Hellman & Friedman.

The collaboration will expedite Medline’s growth and aid in the company’s expansion globally. The deal is said to be valued at more than $30bn.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

A privately held company, Medline manufactures and distributes healthcare supplies, primarily medical equipment, in the US. It reported a revenue of $17.5bn last year.

Medline allies with various healthcare providers across the globe to provide products and solutions that lower costs, boost supply chain efficiency and enhance the quality of care.

The company’s portfolio, customer service, responsiveness and collaboration offer substantial value for its clients, Medline noted.

Medline CEO Charlie Mills said: “This investment from some of the world’s most experienced and successful private investment firms will enable us to accelerate that strategy while preserving the family-led culture that is core to our success.”

Subject to regulatory approvals and necessary closing conditions, the deal is anticipated to conclude later this year. After closing, Medline will remain a privately held company led by the Mills family.

The Mills family will be the major single shareholder in the company and the complete senior management group will remain unchanged.

The company intends to utilise the investment proceeds to increase its product offerings, expand worldwide and finance infrastructure investments to bolster its international supply chain.

Carlyle healthcare global head Steve Wise said: “We are excited to partner with Medline’s impressive management team to accelerate growth through continued execution, innovation and investment.

“With a deep commitment to sustainable value creation, we look forward to leveraging our combined operational capabilities, expansive healthcare network and capital to support organic and inorganic growth initiatives for the company.”

In addition, the Singaporean sovereign wealth fund, GIC, is investing as part of this collaboration.

Goldman Sachs served as lead financial advisor to Medline, while BDT was the financial advisor and Wachtell, Lipton, Rosen & Katz acted as legal advisor.

Last month, Medline signed a definitive agreement to acquire select assets under the Hudson RCI brand of Teleflex’s Respiratory business for $286m in cash.